MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
50 hedge funds and large institutions have $91M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 47 → 50 (+3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
50
Holding in Top 10
2
Calls
$6.79M
Puts
$3.96M
Top Buyers
| 1 | +$6.8M | |
| 2 | +$2.59M | |
| 3 | +$1.76M | |
| 4 |
NM
Newtyn Management
New York
|
+$1.29M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.21M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$1.59M | |
| 3 | -$1.43M | |
| 4 |
O
OrbiMed
New York
|
-$843K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$735K |